Viagra
Product Images NDC 67544-356

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Viagra (NDC 67544-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 50mg (67544 355)

Label for Sildenafil Citrate (Viagra) 50 mg tablets, containing 2 tablets per package. Label indicates repackaging by Aphena Pharma Solutions - Tennessee, LLC, with original manufacturing by Pfizer PGM in Poce Sur Cisse, France. Storage instructions and prescription-only status are also included.*

FDA Label Image

Bottle Label 100mg (67544 356)

Label for Sildenafil Citrate (Viagra) 100 mg tablets, containing 4 tablets. The label states storage instructions between 20-25 degrees Celsius and mentions repackaging by Aphena Pharma Solutions in Cookeville, TN. The original manufacturer is Pfizer PGM, Poce Sur Cisse, France. The product is marked RX Only and includes barcode and batch information fields.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Viagra 01)

Chemical structure of sildenafil citrate, the active ingredient in Viagra. The diagram shows the molecular arrangement of atoms and bonds characteristic of this compound.*

FDA Label Image

Figure 1 (Viagra 02)

A line graph comparing systolic blood pressure changes (mmHg) over 24 hours post dose for Sildenafil 100 mg and placebo. The x-axis represents time in hours after dosing, and the y-axis shows systolic blood pressure values ranging from -25 to 15 mmHg. Two lines depict pressure variation for each treatment over time.*

FDA Label Image

Figure 2 (Viagra 03)

A line chart depicting change in SBP (mmHg) over time postdose (hours). Two data series compare Doxazosin + Placebo (blue line) versus Doxazosin + Sildenafil 25 mg (black line) across an 8-hour period.*

FDA Label Image

Figure 3 (Viagra 04)

A line graph showing the change in SEP (mmHg) on the Y-axis over time postdose in hours on the X-axis (0 to 8 hours). It compares two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg, with the Doxazosin plus Placebo line in blue and the Doxazosin plus Sildenafil 50 mg line in gray. The graph tracks blood pressure changes over an 8-hour period postdose.*

FDA Label Image

Figure 4 (Viagra 05)

A line graph comparing the effect of Doxazosin with Sildenafil 100 mg versus Doxazosin with Placebo on vertical axis measured in mmHg over time after dosing measured in hours from 0 to 8. The graph shows two lines representing each treatment group and their blood pressure changes over time.*

FDA Label Image

Figure 5 (Viagra 06)

A pharmacokinetic curve showing plasma concentration (ng/mL) over 24 hours after a dose of a commercial tablet. The graph plots plasma concentration with an initial sharp rise peaking below 500 ng/mL within the first two hours, followed by a gradual decline over time until near zero at 24 hours.*

FDA Label Image

Figure 6 (Viagra 07)

A bar chart titled 'Effect of VIAGRA on Maintenance of Erection by Baseline Score' showing percentage of patients at endpoint on the vertical axis and baseline score on the horizontal axis. Multiple colored bars represent different score categories for each baseline score from 0 to 5.*

FDA Label Image

Figure 6 (Viagra 08)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint across baseline scores from 0 to 5. The chart includes multiple bars for each baseline score representing different categories labeled 0 through 5 in the legend.*

FDA Label Image

Figure 7 (Viagra 09)

A bar chart showing the percentage of patients reporting improvement across different treatment groups, including placebo and Viagra at doses of 25 mg, 50 mg, and 100 mg. The vertical axis represents the percentage of patients reporting improvement, and the horizontal axis lists the treatment groups with patient counts for each.*

FDA Label Image

Logo (Viagra 10)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.